P3 Health Partners Inc
NASDAQ:PIII
Relative Value
The Relative Value of one PIII stock under the Base Case scenario is 1.667 USD. Compared to the current market price of 0.578 USD, P3 Health Partners Inc is Undervalued by 65%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
PIII Competitors Multiples
P3 Health Partners Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
P3 Health Partners Inc
NASDAQ:PIII
|
344.2m USD | 0.3 | -6 | -5.1 | -2.5 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
97.2B EUR | 0.5 | 20.1 | 10.3 | 13.8 | |
US |
Cigna Corp
NYSE:CI
|
102.4B USD | 0.5 | 19.8 | 10.2 | 13.6 | ||
US |
CVS Health Corp
NYSE:CVS
|
70B USD | 0.2 | 8.4 | 7.8 | 7.8 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.8B EUR | 0.7 | -26.6 | 10.1 | 22.6 | |
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
16.8B USD | 1.4 | 38.9 | 11.8 | 17.8 | ||
US |
Quest Diagnostics Inc
NYSE:DGX
|
15B USD | 1.6 | 17.9 | 10.7 | 14.5 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.8B EUR | 0.6 | 23.7 | 7 | 16.5 | |
US |
DaVita Inc
NYSE:DVA
|
12.5B USD | 1 | 18.1 | 8.7 | 12.7 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
11.4B EUR | 0.6 | 22.8 | 6.8 | 16.2 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |